{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:43:40Z","timestamp":1784641420322,"version":"3.55.0"},"reference-count":228,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001688","name":"International Centre for Genetic Engineering and Biotechnology","doi-asserted-by":"publisher","award":["CRP\/MYS21-04_EC"],"award-info":[{"award-number":["CRP\/MYS21-04_EC"]}],"id":[{"id":"10.13039\/501100001688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004595","name":"Universiti Sains Malaysia","doi-asserted-by":"publisher","award":["304\/PTEKIND\/6315523"],"award-info":[{"award-number":["304\/PTEKIND\/6315523"]}],"id":[{"id":"10.13039\/501100004595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.cellsig.2024.111201","type":"journal-article","created":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T17:37:35Z","timestamp":1714930655000},"page":"111201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Past and present discovery of the BAFF\/APRIL system \u2013 A bibliometric study from 1999 to 2023"],"prefix":"10.1016","volume":"120","author":[{"given":"Muggunna","family":"Balasubramaniam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Masara Ahmad","family":"Mokhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2024.111201_bb0005","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nri799","article-title":"Marginal-zone B cells","volume":"2","author":"Martin","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0010","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/eji.200939633","article-title":"Tolerance checkpoints in B-cell development: Johnny B good","volume":"39","author":"Tussiwand","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0015","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1084\/jem.20042251","article-title":"Defective B cell tolerance checkpoints in systemic lupus erythematosus","volume":"201","author":"Yurasov","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellsig.2024.111201_bb0020","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nri1633","article-title":"Transcriptional networks in developing and mature B cells","volume":"5","author":"Matthias","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0025","series-title":"B-Cell Self-Tolerance in Humans","first-page":"83","author":"Wardemann","year":"2007"},{"key":"10.1016\/j.cellsig.2024.111201_bb0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ncrna.2022.03.001","article-title":"Hotspots and development frontiers of circRNA based on bibliometric analysis","volume":"7","author":"Zhang","year":"2022","journal-title":"Non-Coding RNA Res."},{"key":"10.1016\/j.cellsig.2024.111201_bb0035","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"10.1016\/j.cellsig.2024.111201_bb0040","first-page":"959","article-title":"Bibliometrix: an R-tool for comprehensive science mapping analysis","volume":"11","author":"Aria","year":"2017","journal-title":"J. Inf. Secur."},{"key":"10.1016\/j.cellsig.2024.111201_bb0045","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1084\/jem.189.11.1747","article-title":"BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth","volume":"189","author":"Schneider","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellsig.2024.111201_bb0050","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nri844","article-title":"BAFF: a fundamental survival factor for B cells","volume":"2","author":"Mackay","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0055","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev.immunol.21.120601.141152","article-title":"BAFF and APRIL: a tutorial on B cell survival","volume":"21","author":"Mackay","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0060","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1084\/jem.190.11.1697","article-title":"Mice transgenic for Baff develop lymphocytic disorders along with autoimmune manifestations","volume":"190","author":"Mackay","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellsig.2024.111201_bb0065","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1084\/jem.192.10.1453","article-title":"Baff mediates survival of peripheral immature B lymphocytes","volume":"192","author":"Batten","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellsig.2024.111201_bb0070","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1126\/science.278.5335.138","article-title":"NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily","volume":"278","author":"von Bulow","year":"1997","journal-title":"Science (80-)"},{"key":"10.1016\/j.cellsig.2024.111201_bb0075","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1074-7613(01)00130-3","article-title":"Regulation of the T-independent humoral response by TACI","volume":"14","author":"von B\u00fclow","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.cellsig.2024.111201_bb0080","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/ni829","article-title":"DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL","volume":"3","author":"Litinskiy","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0085","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.4049\/jimmunol.172.5.3268","article-title":"Lymphoma B cells evade apoptosis through the TNF family members BAFF\/BLyS and APRIL","volume":"172","author":"He","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0090","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/ni.1914","article-title":"The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88","volume":"11","author":"He","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat7117","article-title":"Gut T cell\u2013independent IgA responses to commensal bacteria require engagement of the TACI receptor on B cells","volume":"5","author":"Grasset","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0100","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1073\/pnas.0307348101","article-title":"Impaired IgA class switching inn APRIL-deficient mice","volume":"101","author":"Castigli","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellsig.2024.111201_bb0105","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ng1601","article-title":"TACI is mutant in common variable immunodeficiency and IgA deficiency","volume":"37","author":"Castigli","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cellsig.2024.111201_bb0110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20032000","article-title":"TACI and BAFF-R mediate isotype switching in B cells","volume":"201","author":"Castigli","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellsig.2024.111201_bb0115","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2022-eular.771","article-title":"POS0094 ALPN-303, An engineered dual BAFF\/APRIL antagonist potentially inhibits pathogenic lymphocyte subsets and function in B-cell and antibody-related preclinical models","volume":"81","author":"Dillon","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cellsig.2024.111201_bb0120","first-page":"2887","article-title":"APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa","volume":"118","author":"Huard","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2024.111201_bb0125","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/intimm\/dxh043","article-title":"BAFF production by antigen-presenting cells provides T cell co-stimulation","volume":"16","author":"Huard","year":"2004","journal-title":"Int. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1182\/blood-2006-02-001800","article-title":"Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness","volume":"109","author":"Schwaller","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cellsig.2024.111201_bb0135","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.4049\/jimmunol.167.11.6225","article-title":"T cell costimulation by the TNF ligand BAFF","volume":"167","author":"Huard","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0140","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S","article-title":"Elevated serum B lymphocyte stimulator levels in patients with systemic immune\u2013based rheumatic diseases","volume":"44","author":"Cheema","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cellsig.2024.111201_bb0145","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1002\/art.11354","article-title":"B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations","volume":"48","author":"Stohl","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cellsig.2024.111201_bb0150","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/art.34400","article-title":"Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus","volume":"64","author":"Stohl","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cellsig.2024.111201_bb0155","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1084\/jem.188.6.1185","article-title":"APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth","volume":"188","author":"Hahne","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellsig.2024.111201_bb0160","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/cdd.2012.68","article-title":"The TNF family member APRIL promotes colorectal tumorigenesis","volume":"19","author":"Lascano","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cellsig.2024.111201_bb0165","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.4049\/jimmunol.176.11.6405","article-title":"Space, selection, and surveillance: setting boundaries with BLyS","volume":"176","author":"Miller","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0170","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.4049\/jimmunol.168.12.5993","article-title":"Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators","volume":"168","author":"Hsu","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0175","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1084\/jem.20130505","article-title":"Local BLyS production by T follicular cells mediates retention of high affinity B cells during affinity maturation","volume":"211","author":"Goenka","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellsig.2024.111201_bb0180","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.0105-2896.2004.00212.x","article-title":"The BLyS family of ligands and receptors: an archetype for niche-specific homeostatic regulation","volume":"202","author":"Cancro","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cellsig.2024.111201_bb0185","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijhm.2017.06.012","article-title":"Bibliometrics of social media research: a co-citation and co-word analysis","volume":"66","author":"Leung","year":"2017","journal-title":"Int. J. Hosp. Manag."},{"key":"10.1016\/j.cellsig.2024.111201_bb0190","first-page":"22","article-title":"Factors influencing scholarly publication productivity: a systematic review","volume":"50","author":"Wahid","year":"2022","journal-title":"Inf. Discov. Deliv."},{"key":"10.1016\/j.cellsig.2024.111201_bb0195","doi-asserted-by":"crossref","first-page":"6761","DOI":"10.1007\/s11192-021-04059-x","article-title":"Publication patterns\u2019 changes due to the COVID-19 pandemic: a longitudinal and short-term scientometric analysis","volume":"126","author":"Aviv-Reuven","year":"2021","journal-title":"Scientometrics"},{"key":"10.1016\/j.cellsig.2024.111201_bb0200","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1126\/science.285.5425.260","article-title":"BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator","volume":"285","author":"Moore","year":"1999","journal-title":"Science (80-)"},{"key":"10.1016\/j.cellsig.2024.111201_bb0205","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/jlb.65.5.680","article-title":"TALL-1 is a novel member of the TNF family that is down-regulated by mitogens","volume":"65","author":"Shu","year":"1999","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0210","doi-asserted-by":"crossref","first-page":"15978","DOI":"10.1074\/jbc.274.23.15978","article-title":"Identification and characterization of a novel cytokine, THANK, aTNF homologue that activates apoptosis, nuclear factor-\u03baB, and c-Jun NH2-terminal kinase","volume":"274","author":"Mukhopadhyay","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2024.111201_bb0215","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/35010115","article-title":"TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease","volume":"404","author":"Gross","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2024.111201_bb0220","series-title":"APRIL\/TRDL-1, A Tumor Necrosis Factor-like Ligand, Stimulates Cell Death","author":"Kelly","year":"2000"},{"key":"10.1016\/j.cellsig.2024.111201_bb0225","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/sj.cdd.4401291","article-title":"The uncertain glory of APRIL","volume":"10","author":"Medema","year":"2003","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cellsig.2024.111201_bb0230","unstructured":"National Science Board, National Science Foundation. 2019. Publication Output: U.S. Trends and International Comparisons. Science and Engineering Indicators 2020. NSB-2020-6. Alexandria, VA. Available at https:\/\/ncses.nsf.gov\/pubs\/nsb20206\/."},{"key":"10.1016\/j.cellsig.2024.111201_bb0235","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","article-title":"Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK","volume":"401","author":"Conrad","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.cellsig.2024.111201_bb0240","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nri2572","article-title":"Cracking the BAFF code","volume":"9","author":"MacKay","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0245","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1084\/jem.192.11.1677","article-title":"A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member April, inhibits tumor cell growth","volume":"192","author":"Rennert","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellsig.2024.111201_bb0250","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1006\/geno.1999.6062","article-title":"Physical map of 17p13 and the genes adjacent to p53","volume":"63","author":"Cousin","year":"2000","journal-title":"Genomics"},{"key":"10.1016\/j.cellsig.2024.111201_bb0255","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1093\/emboj\/cdf565","article-title":"An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK\u2013APRIL fusion protein","volume":"21","author":"Pradet-Balade","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.cellsig.2024.111201_bb0260","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.autrev.2007.05.002","article-title":"BAFF, APRIL, TWE-PRIL: who\u2019s who?","volume":"7","author":"Daridon","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cellsig.2024.111201_bb0265","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.smim.2006.04.006","article-title":"BAFF, APRIL and their receptors: structure, function and signaling","volume":"18","author":"Bossen","year":"2006","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0270","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4049\/jimmunol.175.1.319","article-title":"\u0394BAFF, a splice isoform of BAFF, opposes full-length BAFF activity in vivo in transgenic mouse models","volume":"175","author":"Gavin","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0275","doi-asserted-by":"crossref","first-page":"38220","DOI":"10.1074\/jbc.M306852200","article-title":"\u0394BAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF","volume":"278","author":"Gavin","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2024.111201_bb0280","series-title":"Immunopathology of Primary Sj\u00f6gren\u2019s Syndrome (Role of B Lymphocyte, FLT3-Ligand and BAFF) and the Clinical Consequences (Doctoral Dissertation)","author":"Tob\u00f3n","year":"2012"},{"key":"10.1016\/j.cellsig.2024.111201_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020787","article-title":"Aberrant expression of functional BAFF-system receptors by malignant B-cell precursors impacts leukemia cell survival","volume":"6","author":"Maia","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2024.111201_bb0290","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.imlet.2020.06.001","article-title":"The roles of B cell activation factor (BAFF) and a proliferation-inducing ligand (APRIL) in allergic asthma","volume":"225","author":"Alturaiki","year":"2020","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cellsig.2024.111201_bb0295","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaut.2012.05.009","article-title":"The complexity of the BAFF TNF-family members: implications for autoimmunity","volume":"39","author":"Lahiri","year":"2012","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cellsig.2024.111201_bb0300","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0092-8674(02)00631-1","article-title":"Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands","volume":"108","author":"Liu","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2024.111201_bb0305","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1021\/bi051685o","article-title":"Formation of virus-like clusters is an intrinsic property of the tumor necrosis factor family member BAFF (B cell activating factor)","volume":"45","author":"Cachero","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.cellsig.2024.111201_bb0310","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/embo-reports\/kve198","article-title":"Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase","volume":"2","author":"L\u00f3pez-Fraga","year":"2001","journal-title":"EMBO Rep."},{"key":"10.1016\/j.cellsig.2024.111201_bb0315","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1002\/j.1460-2075.1992.tb05482.x","article-title":"A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a t(4;16)(q26;p13) translocation in a malignant T cell lymphoma","volume":"11","author":"La\u00e2bi","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.cellsig.2024.111201_bb0320","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s003350010125","article-title":"Molecular cloning and functional characterization of murine transmembrane activator and CAML interactor (TACI) with chromosomal localization in human and mouse","volume":"11","author":"Von B\u00fclow","year":"2000","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.cellsig.2024.111201_bb0325","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1126\/science.1061965","article-title":"BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF","volume":"293","author":"Thompson","year":"2001","journal-title":"Science (80-)"},{"key":"10.1016\/j.cellsig.2024.111201_bb0330","doi-asserted-by":"crossref","first-page":"35478","DOI":"10.1074\/jbc.M005224200","article-title":"Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS*","volume":"275","author":"Wu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2024.111201_bb0335","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0960-9822(00)00566-2","article-title":"Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI","volume":"10","author":"Marsters","year":"2000","journal-title":"Curr. Biol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0340","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1084\/jem.20042309","article-title":"Identification of proteoglycans as the APRIL-specific binding partners","volume":"201","author":"Ingold","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellsig.2024.111201_bb0345","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.cdd.4401647","article-title":"Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation","volume":"12","author":"Hendriks","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cellsig.2024.111201_bb0350","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cytogfr.2013.04.003","article-title":"The BAFF\/APRIL system: emerging functions beyond B cell biology and autoimmunity","volume":"24","author":"Vincent","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cellsig.2024.111201_bb0355","doi-asserted-by":"crossref","first-page":"807","DOI":"10.4049\/jimmunol.173.2.807","article-title":"B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells1","volume":"173","author":"Ng","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0360","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4049\/jimmunol.1001120","article-title":"The structure of the TNFRSF13C promoter enables differential expression of BAFF-R during B cell ontogeny and terminal differentiation","volume":"185","author":"Mihalcik","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0365","doi-asserted-by":"crossref","first-page":"5948","DOI":"10.4049\/jimmunol.0901186","article-title":"Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development1","volume":"183","author":"Alexaki","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0370","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1210\/en.2011-1504","article-title":"B-cell maturation antigen (BCMA) activation exerts specific proinflammatory effects in normal human keratinocytes and is preferentially expressed in inflammatory skin pathologies","volume":"153","author":"Alexaki","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.cellsig.2024.111201_bb0375","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1038\/s41598-021-82346-6","article-title":"B-cells expressing NgR1 and NgR3 are localized to EAE-induced inflammatory infiltrates and are stimulated by BAFF","volume":"11","author":"Bakhuraysah","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2024.111201_bb0380","first-page":"795","article-title":"BAFF is involved in the pathogenesis of IgA nephropathy by activating the TRAF6\/NF-\u03baB signaling pathway in glomerular mesangial cells","volume":"21","author":"Cao","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cellsig.2024.111201_bb0385","article-title":"Renal tissue expression of BAFF and BAFF receptors is associated with proliferative lupus nephritis","volume":"12","author":"Mar\u00edn-Rosales","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cellsig.2024.111201_bb0390","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12882-015-0064-y","article-title":"BAFF promotes proliferation of human mesangial cells through interaction with BAFF-R","volume":"16","author":"Zheng","year":"2015","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0395","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/modpathol.2010.184","article-title":"Intrarenal production of B-cell survival factors in human lupus nephritis","volume":"24","author":"Neusser","year":"2011","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0400","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/79802","article-title":"APRIL and TALL-1 and receptors BCMA and TACI: system for regulating humoral immunity","volume":"1","author":"Yu","year":"2000","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0405","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar3908","article-title":"B-cell subpopulations in humans and their differential susceptibility to depletionwith anti-CD20 monoclonal antibodies","volume":"15","author":"Leandro","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cellsig.2024.111201_bb0410","series-title":"Human B Cell Subsets","first-page":"122","author":"Weill","year":"2016"},{"key":"10.1016\/j.cellsig.2024.111201_bb0415","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.coi.2008.03.014","article-title":"Peripheral B cell subsets","volume":"20","author":"Allman","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0420","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1126\/science.1061964","article-title":"An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway","volume":"293","author":"Schiemann","year":"2001","journal-title":"Science (80-)"},{"key":"10.1016\/j.cellsig.2024.111201_bb0425","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0960-9822(01)00481-X","article-title":"Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency","volume":"11","author":"Yan","year":"2001","journal-title":"Curr. Biol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0430","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1073\/pnas.97.7.3370","article-title":"Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice","volume":"97","author":"Khare","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellsig.2024.111201_bb0435","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/89790","article-title":"Activation and accumulation of B cells in TACI-deficient mice","volume":"2","author":"Yan","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0440","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1074-7613(03)00025-6","article-title":"Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor","volume":"18","author":"Seshasayee","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.cellsig.2024.111201_bb0445","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1084\/jem.194.11.1691","article-title":"Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen","volume":"194","author":"Schneider","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellsig.2024.111201_bb0450","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1074-7613(01)00183-2","article-title":"TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease: impaired B cell maturation in mice lacking BLyS","volume":"15","author":"Gross","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.cellsig.2024.111201_bb0455","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1084\/jem.192.1.129","article-title":"Baff binds to the tumor necrosis factor receptor\u2013like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population","volume":"192","author":"Thompson","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellsig.2024.111201_bb0460","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1128\/MCB.21.12.4067-4074.2001","article-title":"B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses","volume":"21","author":"Xu","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0465","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1084\/jem.20031330","article-title":"BCMA is essential for the survival of long-lived bone marrow plasma cells","volume":"199","author":"O\u2019Connor","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellsig.2024.111201_bb0470","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1128\/MCB.24.3.997-1006.2004","article-title":"APRIL-deficient mice have normal immune system development","volume":"24","author":"Varfolomeev","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0475","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1172\/JCI0215034","article-title":"APRIL modulates B and T cell immunity","volume":"109","author":"Stein","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2024.111201_bb0480","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2004.022491","article-title":"Raised serum APRIL levels in patients with systemic lupus erythematosus","volume":"64","author":"Koyama","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cellsig.2024.111201_bb0485","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1177\/0961203315608254","article-title":"Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus","volume":"25","author":"Salazar-Camarena","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.cellsig.2024.111201_bb0490","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1172\/JCI25265","article-title":"BLyS and APRIL in rheumatoid arthritis","volume":"115","author":"Seyler","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2024.111201_bb0495","first-page":"1256","article-title":"Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis","volume":"35","author":"Bosello","year":"2008","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0500","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI0214121","article-title":"Association of BAFF\/BLyS overexpression and altered B cell differentiation with Sj\u00f6gren\u2019s syndrome","volume":"109","author":"Groom","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2024.111201_bb0505","doi-asserted-by":"crossref","first-page":"321","DOI":"10.5114\/reum.2015.57638","article-title":"The relationship between the presence of autoantibodies, indicators of local and systemic inflammation, the serum concentration of B-cell activating factor (BAFF) and the intensity of salivary gland infiltration in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"53","author":"Maslinska","year":"2015","journal-title":"Reumatologia"},{"key":"10.1016\/j.cellsig.2024.111201_bb0510","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10875-005-4091-5","article-title":"Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sj\u00f6gren\u2019s syndrome","volume":"25","author":"Jonsson","year":"2005","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0515","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jneuroim.2010.01.011","article-title":"Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis","volume":"220","author":"Piazza","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0520","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jneuroim.2008.05.010","article-title":"Serum BAFF expression in patients with myasthenia gravis","volume":"199","author":"Kim","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0525","doi-asserted-by":"crossref","first-page":"R252","DOI":"10.1186\/ar4095","article-title":"APRIL, a proliferation-inducing ligand, as a potential marker of lupus nephritis","volume":"14","author":"Treamtrakanpon","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cellsig.2024.111201_bb0530","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/09612033221086123","article-title":"The relationship between serum A proliferation-inducing ligand and B-cell activating factor levels with disease activity and organ involvement in systemic lupus erythematosus","volume":"31","author":"Sari","year":"2022","journal-title":"Lupus"},{"key":"10.1016\/j.cellsig.2024.111201_bb0535","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/954292","article-title":"The characteristics and significance of locally infiltrating B cells in lupus nephritis and their association with local BAFF expression","volume":"2013","author":"Sun","year":"2013","journal-title":"Int. J. Rheumatol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0540","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1177\/0961203318804885","article-title":"Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus","volume":"27","author":"Vincent","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.cellsig.2024.111201_bb0545","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/cei.12894","article-title":"Urinary B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL): potential biomarkers of active lupus nephritis","volume":"187","author":"Phatak","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0550","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s00296-014-3020-4","article-title":"Increased serum APRIL differentially correlates with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients","volume":"34","author":"Boghdadi","year":"2014","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.cellsig.2024.111201_bb0555","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1177\/0961203314543914","article-title":"APRIL levels strongly correlate with IL-17 in systemic lupus erythematosus","volume":"23","author":"Eilertsen","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.cellsig.2024.111201_bb0560","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2003.018663","article-title":"Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus","volume":"63","author":"Stohl","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cellsig.2024.111201_bb0565","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2008.090928","article-title":"Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus","volume":"68","author":"Morel","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cellsig.2024.111201_bb0570","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/rheumatology\/keg270","article-title":"A novel polymorphism of the human APRIL gene is associated with systemic lupus erythematosus","volume":"42","author":"Koyama","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.cellsig.2024.111201_bb0575","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/rheumatology\/kem019","article-title":"Role of APRIL (TNFSF13) polymorphisms in the susceptibility to systemic lupus erythematosus in Japanese","volume":"46","author":"Kawasaki","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.cellsig.2024.111201_bb0580","first-page":"1","article-title":"Increased April expression induces IgA1 aberrant glycosylation in IgA nephropathy","volume":"95","author":"Zhai","year":"2016","journal-title":"Medicine (United States)"},{"key":"10.1016\/j.cellsig.2024.111201_bb0585","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1681\/ASN.2015060677","article-title":"The role of TNF superfamily member 13 in the progression of IgA nephropathy","volume":"27","author":"Han","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0590","article-title":"Pathogenic role of a proliferation-inducing ligand (APRIL) in murine IgA nephropathy","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2024.111201_bb0595","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.2966","article-title":"Association of TNFSF13 polymorphisms with IgA nephropathy in a Chinese Han population","volume":"19","author":"Zhong","year":"2017","journal-title":"J. Gene Med."},{"key":"10.1016\/j.cellsig.2024.111201_bb0600","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1047","article-title":"Analysis of serum B cell-activating factor from the tumor necrosis factor family (BAFF) and its soluble receptors in systemic lupus erythematosus","volume":"8","author":"Vincent","year":"2019","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0605","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/art.22458","article-title":"Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sj\u00f6gren\u2019s syndrome","volume":"56","author":"Daridon","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cellsig.2024.111201_bb0610","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/art.10860","article-title":"Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis","volume":"48","author":"Tan","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cellsig.2024.111201_bb0615","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/03009740701286615","article-title":"Expression of BAFF and BAFF-R in the synovial tissue of patients with rheumatoid arthritis","volume":"36","author":"Nakajima","year":"2007","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0620","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2012-202382","article-title":"The TNF family member APRIL dampens collagen-induced arthritis","volume":"72","author":"Fernandez","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cellsig.2024.111201_bb0625","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1002\/eji.200838640","article-title":"APRIL (TNFSF13) regulates collagen-induced arthritis, IL-17 production and Th2 response","volume":"38","author":"Xiao","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0630","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2249.2010.04293.x","article-title":"Therapeutic effects of TACI-Ig on rat with adjuvant arthritis","volume":"163","author":"Wang","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0635","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.trim.2017.08.006","article-title":"B-cell activating factor BAFF reflects patients\u2019 immunological risk profile after kidney transplantation","volume":"45","author":"Schuster","year":"2017","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0640","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.895157","article-title":"B-cell response in solid organ transplantation","volume":"13","author":"Yi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0645","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223889","article-title":"Autoantibody production significantly decreased with APRIL\/BLyS blockade in murine chronic rejection kidney transplant model","volume":"14","author":"Bath","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2024.111201_bb0650","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211865","article-title":"Desensitization and treatment with APRIL\/BLyS blockade in rodent kidney transplant model","volume":"14","author":"Bath","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2024.111201_bb0655","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.transproceed.2008.10.024","article-title":"Abnormal high expression of B-cell activating factor belonging to the TNF superfamily (BAFF) associated with long-term outcome in kidney transplant recipients","volume":"41","author":"Xu","year":"2009","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.cellsig.2024.111201_bb0660","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030779","article-title":"High pretransplant BAFF levels and B-cell subset polarized towards a memory phenotype as predictive biomarkers for antibody-mediated rejection","volume":"21","author":"Irure-Ventura","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2024.111201_bb0665","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.trim.2017.12.004","article-title":"Pretransplant serum BAFF levels are associated with pretransplant HLA immunization and renal allograft survival","volume":"47","author":"Friebus-Kardash","year":"2018","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0670","doi-asserted-by":"crossref","first-page":"6654992","DOI":"10.1155\/2021\/6654992","article-title":"Investigating the role of BAFF and its receptors in renal transplant recipients with chronic antibody-mediated rejection","volume":"2021","author":"Afzali","year":"2021","journal-title":"J Immunol Res"},{"key":"10.1016\/j.cellsig.2024.111201_bb0675","doi-asserted-by":"crossref","DOI":"10.1097\/01.TP.0000438211.34842.5e","article-title":"Peripheral B-cell phenotype and BAFF levels are associated with HLA immunization in patients awaiting kidney transplantation","volume":"97","author":"Snanoudj","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.cellsig.2024.111201_bb0680","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00005-016-0428-4","article-title":"Soluble BAFF cytokine levels and antibody-mediated rejection of the kidney allograft","volume":"64","author":"Slavcev","year":"2016","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.cellsig.2024.111201_bb0685","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00005-022-00659-4","article-title":"Monitoring of soluble forms of BAFF system (BAFF, APRIL, sR-BAFF, sTACI and sBCMA) in kidney transplantation","volume":"70","author":"Alfaro","year":"2022","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.cellsig.2024.111201_bb0690","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12882-019-1222-4","article-title":"The association of tumor necrosis factor superfamily 13 with recurrence of immunoglobulin A nephropathy in living related kidney transplantation","volume":"20","author":"Jo","year":"2019","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0695","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13502","article-title":"A proliferation-inducing ligand increase precedes IgA nephropathy recurrence in kidney transplant recipients","volume":"33","author":"Mart\u00edn-Penagos","year":"2019","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.cellsig.2024.111201_bb0700","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1111\/j.1600-6143.2012.04194.x","article-title":"BAFF and BAFF-R levels are associated with risk of long-term kidney graft dysfunction and development of donor-specific antibodies","volume":"12","author":"Thibault-Espitia","year":"2012","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.cellsig.2024.111201_bb0705","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2407-8-76","article-title":"Expression of TNF-superfamily members BAFF and APRIL in breast cancer: immunohistochemical study in 52 invasive ductal breast carcinomas","volume":"8","author":"Pelekanou","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cellsig.2024.111201_bb0710","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00827","article-title":"The TNFSF members APRIL and BAFF and their receptors TACI, BCMA, and BAFFR in oncology, with a special focus in breast cancer","volume":"10","author":"Kampa","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0715","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00384-011-1364-8","article-title":"The haplotypes of TNFRSF17 polymorphisms are associated with colon cancer in a Korean population","volume":"27","author":"Chae","year":"2012","journal-title":"Int. J. Color. Dis."},{"key":"10.1016\/j.cellsig.2024.111201_bb0720","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.clinbiochem.2009.06.019","article-title":"APRIL knockdown suppresses migration and invasion of human colon carcinoma cells","volume":"42","author":"Ding","year":"2009","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cellsig.2024.111201_bb0725","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071367","article-title":"Increased B cell-activating factor promotes tumor invasion and metastasis in human pancreatic cancer","volume":"8","author":"Koizumi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2024.111201_bb0730","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.3892\/mmr.2014.2443","article-title":"Soluble a-proliferation-inducing ligand (sAPRIL), a novel serum biomarker predicting the recurrence and metastasis of pancreatic adenocarcinoma after surgery","volume":"10","author":"Han","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cellsig.2024.111201_bb0735","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1111\/cas.15041","article-title":"The BAFF\/NF\u03baB axis is crucial to interactions between sorafenib-resistant HCC cells and cancer-associated fibroblasts","volume":"112","author":"Gao","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cellsig.2024.111201_bb0740","first-page":"136","article-title":"Plasma B-cell activating factor levels and polymorphisms in hepatitis B-related hepatocellular carcinoma: clinical correlation and prognosis","volume":"39","author":"Khlaiphuengsin","year":"2021","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0745","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.4049\/jimmunol.1102891","article-title":"APRIL binding to BCMA activates a JNK2\u2013FOXO3\u2013GADD45 pathway and induces a G2\/M cell growth arrest in liver cells","volume":"189","author":"Notas","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0750","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.3748\/wjg.v11.i30.4650","article-title":"Functional expression of a proliferation-related ligand in hepatocellular carcinoma and its implications for neovascularization","volume":"11","author":"Okano","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0755","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2407-9-83","article-title":"APRIL is overexpressed in cancer: link with tumor progression","volume":"9","author":"Moreaux","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cellsig.2024.111201_bb0760","doi-asserted-by":"crossref","first-page":"F35","DOI":"10.1084\/jem.192.11.F35","article-title":"April and Baff connect autoimmunity and cancer","volume":"192","author":"Ware","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellsig.2024.111201_bb0765","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01835","article-title":"The dark side of fibroblasts: cancer-associated fibroblasts as mediators of immunosuppression in the tumor microenvironment","volume":"10","author":"Monteran","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0770","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.leukres.2009.03.030","article-title":"BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features","volume":"33","author":"Bojarska-Junak","year":"2009","journal-title":"Leuk. Res."},{"key":"10.1016\/j.cellsig.2024.111201_bb0775","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s12185-010-0567-z","article-title":"Differential effects of BAFF on B cell precursor acute lymphoblastic leukemia and Burkitt lymphoma","volume":"91","author":"Onda","year":"2010","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0780","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1365-2141.2007.06615.x","article-title":"High serum levels of B-lymphocyte stimulator are associated with clinical\u2013pathological features and outcome in classical Hodgkin lymphoma","volume":"137","author":"Tecchio","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0785","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1182\/blood-2006-04-015958","article-title":"Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL","volume":"109","author":"Chiu","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cellsig.2024.111201_bb0790","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1182\/blood-2004-02-0762","article-title":"Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome","volume":"104","author":"Novak","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cellsig.2024.111201_bb0795","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.3892\/ol.2017.6528","article-title":"Characteristics of BAFF and APRIL factor expression in multiple myeloma and clinical significance","volume":"14","author":"Pan","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.cellsig.2024.111201_bb0800","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.leukres.2013.05.014","article-title":"Evaluation of TNF superfamily molecules in multiple myeloma patients: correlation with biological and clinical features","volume":"37","author":"Lemancewicz","year":"2013","journal-title":"Leuk. Res."},{"key":"10.1016\/j.cellsig.2024.111201_bb0805","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/389579","article-title":"Relationship between circulating BAFF serum levels with proliferating markers in patients with multiple myeloma","volume":"2013","author":"Alexandrakis","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.cellsig.2024.111201_bb0810","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1182\/blood-2005-09-3552","article-title":"B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstr\u00f6m macroglobulinemia","volume":"107","author":"Elsawa","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cellsig.2024.111201_bb0815","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2002-02-0558","article-title":"Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival","volume":"100","author":"Novak","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cellsig.2024.111201_bb0820","doi-asserted-by":"crossref","DOI":"10.1097\/01.all.0000191887.89773.cc","article-title":"TACItly changing tunes: farewell to a yin and yang of BAFF receptor and TACI in humoral immunity?: new genetic defects in common variable immunodeficiency","volume":"5","author":"Salzer","year":"2005","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0825","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ng1600","article-title":"Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans","volume":"37","author":"Salzer","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cellsig.2024.111201_bb0830","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10875-014-0047-y","article-title":"Reduced BAFF-R and increased TACI expression in common variable immunodeficiency","volume":"34","author":"Barbosa","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0835","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1172\/JCI69854","article-title":"CVID-associated TACI mutations affect autoreactive B cell selection and activation","volume":"123","author":"Romberg","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2024.111201_bb0840","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jaci.2012.10.029","article-title":"TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes","volume":"131","author":"Martinez-Gallo","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0845","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2249.2008.03863.x","article-title":"TACI mutations and disease susceptibility in patients with common variable immunodeficiency","volume":"156","author":"Poodt","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0850","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11882-996-0004-9","article-title":"TACI mutation in common variable immunodeficiency and IgA deficiency","volume":"6","author":"Rachid","year":"2006","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.cellsig.2024.111201_bb0855","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1182\/blood-2008-02-141937","article-title":"Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes","volume":"113","author":"Salzer","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cellsig.2024.111201_bb0860","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s10875-012-9717-9","article-title":"Three different classifications, B lymphocyte subpopulations, TNFRSF13B (TACI), TNFRSF13C (BAFF-R), TNFSF13 (APRIL) gene mutations, CTLA-4 and ICOS gene polymorphisms in Turkish patients with common variable immunodeficiency","volume":"32","author":"Kutukculer","year":"2012","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0865","doi-asserted-by":"crossref","first-page":"13945","DOI":"10.1073\/pnas.0903543106","article-title":"B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans","volume":"106","author":"Warnatz","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cellsig.2024.111201_bb0870","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s10875-005-5637-2","article-title":"Mutational analysis of human BAFF receptor TNFRSF13C (BAFF-R) in patients with common variable immunodeficiency","volume":"25","author":"Losi","year":"2005","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0875","doi-asserted-by":"crossref","DOI":"10.1097\/BOR.0b013e3282f5e08d","article-title":"New approaches of B-cell-directed therapy: beyond rituximab","volume":"20","author":"D\u00f6rner","year":"2008","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0880","doi-asserted-by":"crossref","first-page":"R167","DOI":"10.1186\/ar2076","article-title":"Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"8","author":"Vallerskog","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cellsig.2024.111201_bb0885","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2006.060772","article-title":"Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production","volume":"66","author":"Lavie","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cellsig.2024.111201_bb0890","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1002\/art.11299","article-title":"Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator","volume":"48","author":"Baker","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cellsig.2024.111201_bb0895","first-page":"464","article-title":"Belimumab human genome sciences\/Cambridge antibody technology\/GlaxoSmithKline","volume":"7","author":"Ding","year":"2006","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.cellsig.2024.111201_bb0900","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s13075-015-0741-z","article-title":"Treatment of systemic lupus erythematosus patients with the BAFF antagonist \u201cpeptibody\u201d blisibimod (AMG 623\/A-623): results from randomized, double-blind phase 1a and phase 1b trials","volume":"17","author":"Stohl","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cellsig.2024.111201_bb0905","first-page":"121","article-title":"Generation and characterization of tabalumab, a human monoclonal antibody that neutralizes both soluble and membrane-bound B-cell activating factor","volume":"7","author":"Manetta","year":"2014","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.cellsig.2024.111201_bb0910","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2013-205067","article-title":"Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)","volume":"74","author":"Isenberg","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cellsig.2024.111201_bb0915","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1358\/dot.2022.58.1.3352743","article-title":"Telitacicept, a novel humanized, recombinant TACI-fc fusion protein, for the treatment of systemic lupus erythematosus","volume":"58","author":"Fan","year":"2022","journal-title":"Drugs Today (Barc.)"},{"key":"10.1016\/j.cellsig.2024.111201_bb0920","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/art.42462","article-title":"Povetacicept, an enhanced dual APRIL\/BAFF antagonist that modulates B lymphocytes and pathogenic autoantibodies for the treatment of lupus and other B cell\u2013related autoimmune diseases","volume":"75","author":"Evans","year":"2023","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0925","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molimm.2020.11.010","article-title":"A novel BAFF antagonist, BAFF-trap, effectively alleviates the disease progression of systemic lupus erythematosus in MRL\/lpr mice","volume":"129","author":"Yu","year":"2021","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0930","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41392-019-0051-z","article-title":"Therapeutic effects of a novel BAFF blocker on arthritis","volume":"4","author":"Zhou","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cellsig.2024.111201_bb0935","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2021.101465","article-title":"BLyS neutralization results in selective anti-HLA alloantibody depletion without successful desensitization","volume":"69","author":"Agarwal","year":"2021","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0940","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0140-6736(21)02251-0","article-title":"Safety and efficacy of subcutaneous Ianalumab (VAY736) in patients with primary Sj\u00f6gren\u2019s syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial","volume":"399","author":"Bowman","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.cellsig.2024.111201_bb0945","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2020-eular.364","article-title":"OP0302 Ianalumab (VAY736), a dual mode of action biologic combining BAFF receptor inhibition with B cell depletion, reachers primary endpoint for treatment of primary Sj\u00f6gren\u2019s syndrome","volume":"79","author":"D\u00f6rner","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cellsig.2024.111201_bb0950","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2018-214720","article-title":"Treatment of primary Sj\u00f6gren\u2019s syndrome with Ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity","volume":"78","author":"D\u00f6rner","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cellsig.2024.111201_bb0955","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1182\/blood-2021-147775","article-title":"Investigating the addition of Ianalumab (VAY736) to ibrutinib in patients with chronic lymphocytic leukemia (CLL) on ibrutinib therapy: results from a phase Ib study","volume":"138","author":"Rogers","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.cellsig.2024.111201_bb0960","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood-2020-137629","article-title":"Phase Ib study of Ianalumab (VAY736) and ibrutinib in patients with chronic lymphocytic leukemia (CLL) on ibrutinib therapy","volume":"136","author":"Rogers","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.cellsig.2024.111201_bb0965","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.intimp.2017.01.021","article-title":"Chicoric acid suppresses BAFF expression in B lymphocytes by inhibiting NF-\u03baB activity","volume":"44","author":"Chen","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0970","doi-asserted-by":"crossref","first-page":"109027","DOI":"10.18632\/oncotarget.22561","article-title":"Tripterygium wilfordii inhibits tonsillar IgA production by downregulating IgA class switching in IgA nephropathy","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2024.111201_bb0975","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1084\/jem.192.1.137","article-title":"Taci is a Traf-interacting receptor for Tall-1, a tumor necrosis factor family member involved in B cell regulation","volume":"192","author":"Xia","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellsig.2024.111201_bb0980","doi-asserted-by":"crossref","first-page":"9156","DOI":"10.1073\/pnas.160213497","article-title":"B cell maturation protein is a receptor for the tumor necrosis factor family member TALL-1","volume":"97","author":"Shu","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cellsig.2024.111201_bb0985","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.4049\/jimmunol.165.3.1322","article-title":"TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-\u03baB, Elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase1","volume":"165","author":"Hatzoglou","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0990","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.4049\/jimmunol.169.12.6883","article-title":"TNFR-associated factor-3 is associated with BAFF-R and negatively regulates BAFF-R-mediated NF-\u03baB activation and IL-10 production","volume":"169","author":"Xu","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb0995","doi-asserted-by":"crossref","first-page":"7394","DOI":"10.4049\/jimmunol.173.12.7394","article-title":"Key molecular contacts promote recognition of the BAFF receptor by TNF receptor-associated factor 3: implications for intracellular signaling regulation1","volume":"173","author":"Ni","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb1000","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1074-7613(00)80497-5","article-title":"Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses","volume":"5","author":"Xu","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.cellsig.2024.111201_bb1005","doi-asserted-by":"crossref","first-page":"26243","DOI":"10.1074\/jbc.M403286200","article-title":"Regulation of the NF-\u03baB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation","volume":"279","author":"Liao","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2024.111201_bb1010","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.immuni.2004.09.011","article-title":"TRAF2 differentially regulates the canonical and noncanonical pathways of NF-\u03baB activation in mature B cells","volume":"21","author":"Grech","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.cellsig.2024.111201_bb1015","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.immuni.2004.09.001","article-title":"Act1, a negative regulator in CD40- and BAFF-mediated B cell survival","volume":"21","author":"Qian","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.cellsig.2024.111201_bb1020","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/ni842","article-title":"BAFF-induced NEMO-independent processing of NF-\u03baB2 in maturing B cells","volume":"3","author":"Claudio","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb1025","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.coi.2021.06.014","article-title":"BAFF signaling in health and disease","volume":"71","author":"Schweighoffer","year":"2021","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb1030","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood-2003-06-1984","article-title":"BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone","volume":"103","author":"Moreaux","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cellsig.2024.111201_bb1035","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1182\/blood-2005-10-4042","article-title":"Constitutive NF-\u03baB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas","volume":"107","author":"Fu","year":"2006","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/j.cellsig.2024.111201_bb1040","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/onc.2009.39","article-title":"BH3-only proteins in apoptosis and beyond: an overview","volume":"27","author":"Lomonosova","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2024.111201_bb1045","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/sj.leu.2404228","article-title":"BAFF and APRIL as osteoclast-derived survival factors for myeloma cells: a rationale for TACI-fc treatment in patients with multiple myeloma","volume":"20","author":"Abe","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.cellsig.2024.111201_bb1050","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/cdd.2015.8","article-title":"Combined loss of the BH3-only proteins Bim and Bmf restores B-cell development and function in TACI-Ig transgenic mice","volume":"22","author":"Woess","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cellsig.2024.111201_bb1055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb1060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.564699","article-title":"Bacterial lipoproteins induce BAFF production via TLR2\/MyD88\/JNK signaling pathways in dendritic cells","volume":"11","author":"Im","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb1065","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2011.150219","article-title":"A BAFF\/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells","volume":"70","author":"Bombardieri","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cellsig.2024.111201_bb1070","doi-asserted-by":"crossref","first-page":"196","DOI":"10.5603\/FHC.2012.0029","article-title":"TLR4 ligation induces expression of APRIL molecule in human neutrophils - a preliminary study","volume":"50","author":"Jab\u0142o\u0144ska","year":"2012","journal-title":"Folia Histochem. Cytobiol."},{"key":"10.1016\/j.cellsig.2024.111201_bb1075","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.4049\/jimmunol.178.12.7531","article-title":"TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells","volume":"178","author":"Treml","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb1080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1600-0609.2010.01534.x","article-title":"TLR7 regulates dendritic cell-dependent B-cell responses through BlyS in immune thrombocytopenic purpura","volume":"86","author":"Yu","year":"2011","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.cellsig.2024.111201_bb1085","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/eji.201646861","article-title":"BAFF augments IgA2 and IL-10 production by TLR7\/8 stimulated total peripheral blood B cells","volume":"48","author":"den Hartog","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb1090","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.kint.2019.08.022","article-title":"TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6\u2013mediated pathways in IgA nephropathy","volume":"97","author":"Makita","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2024.111201_bb1095","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2016050496","article-title":"Toll-like receptor 9 stimulation induces aberrant expression of a proliferation-inducing ligand by tonsillar germinal center B cells in IgA nephropathy","volume":"28","author":"Muto","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2024.111201_bb1100","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jaci.2011.04.052","article-title":"Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation","volume":"128","author":"Ozcan","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb1105","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/rheumatology\/ket006","article-title":"Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF","volume":"52","author":"Abu-Rish","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.cellsig.2024.111201_bb1110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/08916934.2010.509122","article-title":"Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation","volume":"44","author":"Kim","year":"2011","journal-title":"Autoimmunity"},{"key":"10.1016\/j.cellsig.2024.111201_bb1115","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/eji.200636800","article-title":"Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion","volume":"37","author":"Katsenelson","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb1120","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.4049\/jimmunol.1601746","article-title":"Human plasmacytoid dendritic cells display and shed B cell maturation antigen upon TLR engagement","volume":"198","author":"Schuh","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb1125","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1002\/eji.200737210","article-title":"Specific TLR ligands regulate APRIL secretion by dendritic cells in a PKR-dependent manner","volume":"37","author":"Hardenberg","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb1130","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/icb.2008.17","article-title":"Thymus-independent class switch recombination is affected by APRIL","volume":"86","author":"Hardenberg","year":"2008","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.cellsig.2024.111201_bb1135","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/eji.201242945","article-title":"Naturally occurring mutation affecting the MyD88-binding site of TNFRSF13B impairs triggering of class switch recombination","volume":"43","author":"Almejun","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cellsig.2024.111201_bb1140","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/eji.201041194","article-title":"Synovial fibroblasts promote immunoglobulin class switching by a mechanism involving BAFF","volume":"41","author":"Alsaleh","year":"2011","journal-title":"Eur. J. Immunol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656824001694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656824001694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:24:49Z","timestamp":1777580689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656824001694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":228,"alternative-id":["S0898656824001694"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2024.111201","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Past and present discovery of the BAFF\/APRIL system \u2013 A bibliometric study from 1999 to 2023","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2024.111201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111201"}}